SCHEMBL29638531

SCHEMBL29638531

Cc1ccc(Nc2nccc3cc(C)ccc23)c(F)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 7/20 0.53
HDAC1 Q13547 7/20 0.53
HDAC6 Q9UBN7 7/20 0.53
KDR P35968 6/20 0.43
RAF1 P04049 1/20 0.43
BRAF P15056 1/20 0.43
FLT1 P17948 5/20 0.39
FGFR1 P11362 4/20 0.39
EGFR P00533 3/20 0.39
FLT4 P35916 3/20 0.39
GRM4 Q14833 1/20 0.38
KDM4E B2RXH2 1/20 0.38
RET P07949 1/20 0.37
KIF5B P33176 1/20 0.37
HTR1A P08908 1/20 0.37
ADRA1D P25100 1/20 0.37
ADRA1A P35348 1/20 0.37
ADRA1B P35368 1/20 0.37
CSF1R P07333 1/20 0.37
LRRK2 Q5S007 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29638530 0.90 HDAC3 (0.44) HDAC3HDAC1HDAC6KDRRAF1
SCHEMBL29638511 0.88 DYRK1A (0.47) HDAC3HDAC1HDAC6KDRRAF1
SCHEMBL29638608 0.86 HDAC3 (0.46) HDAC3HDAC1HDAC6KDRRAF1
SCHEMBL29638713 0.81 RAPGEF4 (0.41) HDAC3HDAC1HDAC6HTR1AADRA1D
SCHEMBL29638579 0.80 TRPA1 (0.44) HDAC3HDAC1HDAC6KDRGRM4
SCHEMBL26210494 0.80 HDAC3 (0.44) HDAC3HDAC1HDAC6KDRRAF1
SCHEMBL15108911 0.78 WNT3A (0.40) KDM4EHTR1AADRA1DADRA1AADRA1B
SCHEMBL15179563 0.77 KDR (0.49) HDAC3HDAC1HDAC6KDRRAF1
SCHEMBL8297790 0.76 WNT3A (0.41) KDM4EHTR1AADRA1DADRA1AADRA1B
SCHEMBL13686770 0.76 MAPK1 (0.56) EGFRKDM4ELRRK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022089219-A1 ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-05-05 WO disclosed